BIOGEN IDEC (NASDAQ:BIIB)
54.36
+0.27 (0.50%)
| BIOGEN IDEC (NASDAQ:BIIB) Delayed : |
| Previous Close |
$54.09 |
|
52 Week High |
$55.37 |
|
| Open |
$54.20 |
|
52 Week Low |
$5.93 |
| Day High |
$54.59 |
|
P/E |
18.24 |
| Day Low |
$54.10 |
|
EPS |
$2.98 |
| Volume |
596,319 |
|
|
|
| More BIIB Info:
Chart
SEC Filings
Profile
Historical
Options
|
Biogen Idec Summary
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid ...more
Executives
James C. Mullen - CEO
Links
http://www.biogenidec.com
View All ReportsStreetInsider.com Reports on BIIB
-
Feb 9, 2010 08:51 AM
Biogen Idec (BIIB) Reports Solid Q4 Profits and Provides Better-than-Expected Outlook
-
Feb 9, 2010 07:16 AM
Biogen (BIIB) Reports Q4 Adj-EPS of $1.20, Beats by 15c; Guides FY10 Above the Street
-
Feb 8, 2010 03:34 PM
Trading Radar for 02/09: Coca-Cola (KO), Pulte Homes (PHM), Agrium (AGU), BJ Services (BJS), Baidu.com (BIDU) Report
-
Feb 8, 2010 11:44 AM
Biogen Idec (BIIB) March volatility flat into EPS and outlook
-
Feb 5, 2010 12:07 PM
FDA Issues Alert on Biogen's (BIIB) Tysabri: Continued Use Increases Risk of Developing PML
View All Reports
StreetInsider Reports on BIIB by Category
-
Feb 9, 2010 05:18 PM
Biogen Idec, Inc. Q4 2009 Earnings Call Transcript
-
Feb 9, 2010 03:15 PM
Post Earnings, Biogen Idec (BIIB) Sees Unusual Options Activity
-
Feb 9, 2010 12:40 PM
Tuesday Options Update: BIIB, USO, MAC & NLY
-
Feb 8, 2010 06:03 AM
12 S&P 500 Stocks with Attractive Valuations
-
Feb 5, 2010 04:30 PM
Closing Bell: The Awful Day That Wasn't So Awful (ARG, APD, JPM, CSCO, N, BIDU, BIIB)
View All Blogs
Comments on BIIB
No comments are currently available.
on Jan 6, 2010
at 05:59 PM GILD Man, that Morgan Stanley analyst sure hates him some Gilead. He may or may not be right about the pipeline, but the share price already reflects his concerns and then some.
Article: Morgan Stanley Gives a Preview for Biotech's Q4 Earnings (GILD, CELG, BIIB, GENZ, More...)
on Sep 21, 2009
at 07:20 PM Dell and Perot Interesting
Article: Notable Mergers and Acquisitions of the Day 9/21: DELL/PER, HK, IMA, BIIB/FACT
on Jan 29, 2009
at 07:08 PM Clueless! They probably have large investments in TEVA Pharmaceuticals
Article: Brean Murray Initiates Coverage on Biogen Idec (BIIB) with a Sell
on Jan 29, 2009
at 06:16 AM What a bunch of Idiots Who would listen to a sub par investment bank like Brean Murray Carret? Disregard the sell - look at the pipeline! I'm expecting good earnings for Q4
Article: Brean Murray Initiates Coverage on Biogen Idec (BIIB) with a Sell
on Jan 28, 2009
at 09:10 PM re: 5 consecutive knockouts What are these guys thinking? BIIB will continue to surprise us with top notch earnings and a terrific pipeline.
Article: Brean Murray Initiates Coverage on Biogen Idec (BIIB) with a Sell